GlassScriptPhysician profile
Mary Montague
NPI 1891291456
$897.43
in general payments reported to CMS, 2019-2025
18 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $34.63 · 2023: $322 · 2024: $277 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $181.52 | 2022-2025 | |
| Exeltis, USA INC. | $168.54 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $66.97 | 2023-2025 | Coolseal Generator, Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Shield Therapeutics INC | $56.83 | 2023-2024 | Accrufer |
| Sage Therapeutics, LLC | $55.58 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $47.94 | 2024 | Veozah |
| Baxter Healthcare | $47.16 | 2025 | Tisseel |
| Mayne Pharma Commercial LLC | $39.07 | 2025 | |
| Daiichi Sankyo INC. | $38.40 | 2023 | Injectafer |
| Channel Medsystems, INC. | $31.16 | 2024 | |
| Sumitomo Pharma America, INC. | $29.83 | 2023 | Myfembree |
| Gynesonics, INC. | $29.69 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Innovation Technologies INC | $20.36 | 2024 | Irrisept |
| Medtronic, INC. | $19.11 | 2025 | Interstim |
| Myovant Sciences INC. | $18.53 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.29 | 2024 | |
| Agile Therapeutics, INC. | $15.30 | 2023 | Twirla |
| Organon LLC | $15.15 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Montague listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.